SQY Therapeutics
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy
Phase 1
Recruiting
- Conditions
- Duchenne Muscular Dystrophy
- Interventions
- Drug: Phase 1, SQY51Drug: Phase 2a, SQY51 (cohort 3)Drug: Phase 2a, SQY51 (cohort 1)Drug: Phase 2a, SQY51 (cohort 2)
- First Posted Date
- 2023-03-03
- Last Posted Date
- 2024-04-01
- Lead Sponsor
- Sqy Therapeutics
- Target Recruit Count
- 12
- Registration Number
- NCT05753462
- Locations
- 🇫🇷
Hôpital Raymond Poincaré, Garches, France
News
No news found